ZFP839 inhibitors represent a specific class of chemical compounds designed to interfere with the activity of ZFP839, a zinc finger protein. Zinc finger proteins, like ZFP839, are characterized by their structural domains, which coordinate one or more zinc ions to stabilize the protein fold. These domains typically interact with nucleic acids, particularly DNA, allowing the proteins to act as transcription factors, regulating gene expression. ZFP839 specifically is thought to play a role in the regulation of genes involved in critical cellular processes such as development, differentiation, and growth. Inhibitors of ZFP839 are designed to modulate this activity, either by directly binding to the zinc finger motifs or by altering the protein's conformation, thus impacting its interaction with DNA or other associated molecular components. These inhibitors may be chemically diverse, ranging from small molecules to larger complexes capable of interacting with the zinc finger motifs.
The specificity of ZFP839 inhibitors is largely dependent on their ability to recognize and bind the structural and functional features of the protein. Research into the mechanisms of inhibition often focuses on structural analyses, such as crystallography or nuclear magnetic resonance (NMR), to identify key binding sites and conformational changes induced by the inhibitors. Additionally, the design and optimization of ZFP839 inhibitors typically involve extensive biochemical assays to determine their affinity, selectivity, and mode of action. These inhibitors can serve as valuable tools in the study of ZFP839's biological function, allowing researchers to dissect the pathways and networks regulated by this transcription factor, furthering understanding of its molecular role in various cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can alter gene expression, potentially affecting ZNF839. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting the methylation status of ZNF839 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, altering chromatin structure and gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, potentially modifying ZNF839 expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, possibly influencing transcription factors including ZNF839. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, affecting gene regulation and expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor, could impact the expression of genes like ZNF839. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, could affect the methylation status of ZNF839 gene regions. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor, affecting gene expression broadly, including ZNF839. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
A BET bromodomain inhibitor, which may impact the regulation of ZNF839 and associated genes. | ||||||